Hospital Core Laboratory
Automation, assay mix, autoverification, cold-chain, and LIS/HL7 FHIR handoff. Debate consolidating chemistry/immunoassay onto a track versus expanding bedside POCT under ISO 15189-aligned quality oversight.
Clinical applications
Start with the care setting and verification burden—not a model number. Centralized high-throughput labs and distributed POCT programs answer different questions about LOD, coefficient of variation (CV), turnaround, HL7/LIS ownership, and CAP/CLIA QC frequency.
Setting pillars
Automation, assay mix, autoverification, cold-chain, and LIS/HL7 FHIR handoff. Debate consolidating chemistry/immunoassay onto a track versus expanding bedside POCT under ISO 15189-aligned quality oversight.
Batch economics, courier logistics, LOD for low-prevalence panels, method comparison studies, and CAP/CLIA oversight at multi-site scale.
Compact footprint, operator competency records, rapid result routing to clinic EMR, and limited biomedical coverage windows for MTTR planning.
Room turnover, limited test menus, and middleware simplicity so exception reasons remain visible when the EMR interface lags.
Minutes-to-result, device lockout, QC frequency, operator ID audit trails, and connectivity fallback when the network drops—the center-lab vs POCT dispute in practice.
Contamination zoning, extraction recovery, IEC 62304 software version control, unidirectional workflow, and wipe-test evidence before patient reporting.
Planning scenarios
“If we move immunoassays onto a connected track, which CV and carryover studies must we repeat before patient reporting?”
“Does bedside testing reduce length of stay enough to justify decentralized QC and operator competency overhead?”
“Can middleware preserve autoverification logic and still expose exception reasons to the LIS during downtime?”
Describe your care setting, volume envelope, and whether you are consolidating or decentralizing testing.
Start a Setting Review